Executive Summary
•CRM trades at 14.3x NTM P/E, with its blended forward P/E of 14.7x sitting 88% below its 2y average forward multiple, as the market questions AI monetisation and margin durability.
•Revenue growth is decelerating to +9.9% NTM, with seat based licensing under pressure while Data Cloud and AI consumption grow triple digits from a small base.
•Agentforce ARR is not separately disclosed but is the key swing factor for a re rating; consumption based pricing via Flex Credits could drive expansion revenue if adoption accelerates.
•Non GAAP operating margin expansion toward the mid 30s is credible, but GAAP margins remain weighed by stock based compensation and Informatica amortisation; buyback capacity is strong at $20b while M&A integration risk persists.
Financial Snapshot
•Revenue: $43.94b TTM
•Revenue growth: +9.9% NTM consensus
•EPS: $10.36 TTM GAAP
•EPS: $16.75 NTM non GAAP
•Gross margin: 77.3% TTM
•Operating margin: 21.4% TTM GAAP
•Operating margin: ~32% non GAAP
•Net margin: 22.0% TTM
•ROE: 19.4%
•Debt/Equity: 110.4%
•Free cash flow: Not disclosed
Forward Outlook
•NTM revenue: $46.29b (+9.9% YoY)
•NTM EPS: $16.75 non GAAP
•FY+2 revenue: $50.87b (+9.9% YoY)
•FY+2 EPS: $16.07 (-4.1% vs NTM)
•Non GAAP operating margin: expected to expand to 33-34% by FY2027
•cRPO growth: decelerating to ~10% (Not disclosed in provided data)
•Agentforce ARR: Not disclosed
•Data Cloud and AI consumption: growing triple digits YoY from a small base
Valuation Analysis
•NTM P/E: 14.3x
•NTM P/S: 4.26x
•NTM EV/EBIT: 10.4x (blended forward metric)
•Trailing P/E: 23.1x
•Trailing P/S: 5.1x
•Blended forward P/E: 14.7x vs 2y avg 118.1x (-88%)
•Blended forward EV/EBITDA: 9.2x vs 2y avg 63.2x (-85%)
•Blended forward EV/Rev: 4.5x vs 2y avg 6.3x (-28%)
•MSFT: ~30.8x TTM P/E, cloud/AI leadership, superior margins
•NOW: ~87.0x TTM P/E, premium for high growth and AI workflow
•ADBE: ~13.2x TTM P/E, similar multiple but lower growth
•ORCL: ~22.5x TTM P/E, cloud infrastructure and AI backlog
•Consensus price target: $271.91
•Median price target: $275
•Price target range: $215-$325
•Our fair value: $270 (16x NTM non GAAP EPS of $16.75)
Key Risks & Catalysts
Risks
•Macro driven deal scrutiny lengthens sales cycles and pressures cRPO growth.
•Seat based licensing deceleration accelerates as AI agents reduce the need for human seats.
•Agentforce monetisation slower than expected, with consumption pricing failing to offset seat declines.
•Informatica integration risk across culture, technology, and customer overlap.
•Margin pressure from AI investment and stock based compensation keeps GAAP profitability volatile.
•Debt/equity of 110.4% limits financial flexibility if rates stay elevated.
•Insider activity skews negative: net -$173k over 90 days, with director Conway Craig selling $1.17m against a $1.0m buy from director Kirk David Blair.
Catalysts
•Agentforce ARR disclosure showing acceleration, potentially exceeding $500m in FY2027.
•Data Cloud and AI consumption revenue growth above 100% YoY driving expansion revenue.
•Non GAAP operating margin expansion ahead of guidance, demonstrating cost discipline.
•Accelerated buyback execution under the $20b authorisation, supporting EPS.
•Informatica synergies realised faster than expected, boosting cross sell.
•Further analyst upgrades following B of A's move to Buy on 12 October 2026, triggering multiple expansion.
Investment Thesis
Salesforce is a high quality franchise trading at a deep discount to its own history and peers, with the market pricing in structural concerns around AI cannibalisation and slowing growth. A 14.3x NTM P/E is undemanding for a business with 77% gross margins, 19% ROE, and a $20b buyback, though free cash flow detail is not disclosed in the current data.
The debate is whether Agentforce and Data Cloud can reaccelerate growth fast enough to offset seat based deceleration. The -4.1% FY+2 EPS revision reflects AI investment and Informatica integration costs, but revenue is still compounding at ~10% and non GAAP margins are guided toward 33-34% by FY2027. At 16x NTM non GAAP EPS of $16.75, we see fair value at $270, roughly in line with the $271.91 consensus target and implying ~13% upside from $239.49.
We recommend Buy with a $270 price target. Key catalysts are Agentforce ARR disclosure, margin delivery, and buyback execution; key risks are macro driven deal scrutiny, slower AI monetisation, and Informatica integration missteps.
